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Mutations in the MYH9 gene, coding for the non-muscle
myosin heavy chain IIA (NMHC-IIA), are responsible for
syndromes characterized by macrothrombocytopenia
associated with deafness, cataracts, and severe glomerular
disease. Electron microscopy of renal biopsies from these
patients found glomerular abnormalities characterized by
alterations in mesangial cells, podocytes, and thickening of
the glomerular basement membrane. Knockout of NMHC-IIA
in mice is lethal, and therefore little is known about the
glomerular-related functions of Myh9. Here, we use zebrafish
as a model to study the role and function of zNMHC-IIA
in the glomerulus. Knockdown of zNMHC-IIA resulted in
malformation of the glomerular capillary tuft characterized
by few and dilated capillaries of the pronephros. In
zNMHC-IIA morphants, endothelial cells failed to develop
fenestrations, mesangial cells were absent or reduced, and
the glomerular basement membrane appeared nonuniformly
thickened. Knockdown of zNMHC-IIA did not impair the
formation of podocyte foot processes or slit diaphragms;
however, podocyte processes were less uniform in these
morphants compared to controls. In vivo clearance of
fluorescent dextran indicated that the glomerular barrier
function was not compromised by zNMHC-IIA knockdown;
however, glomerular filtration was significantly reduced.
Thus, our results demonstrate an important role of zNMHC-
IIA for the proper formation and function of the glomerulus
in zebrafish.
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Non-muscle myosin II (NM-II) is critically important in cell
contractility, morphology, cytokinesis, polarity, and migra-
tion.1–5 In mammalian cells, three different genes (Myh9,
Myh10, and Myh14) encode three different non-muscle
myosin heavy chains (NMHCs), referred to as NMHC-IIA,
NMHC-IIB, and NMHC-IIC.6,7 The present work focuses on
the role of NMHC-IIA. Several mutations in MYH9 have
been identified (e.g., R702, R1165, D1424, E1841, or R1933)
in the past, which are responsible for a variety of autosomal-
dominant, so-called MYH9-related diseases such as Epstein,
Fechtner, Sebastian Syndrome, and May–Hegglin anom-
aly.8–10 All of them are characterized by macrothrombo-
cytopenia accompanied by sensoneural injury, cataracts,
Do¨hle-like inclusions in neutrophils, and glomerular injury.
In addition, clinical studies have reported a causal connection
between MYH9 mutations and glomerulosclerosis11–14 and
end-stage renal disease.15–16 To date, 39 mutations have been
found, several of which are associated with severe glomerular
syndromes, such as foot process effacement of podocytes,
and focal glomerular basement membrane (GBM) thickening
and splitting, resulting in proteinuria and finally end-stage
renal disease (reviewed by Kopp et al.).17
The molecular mechanisms responsible for these MYH9-
related glomerular diseases are not understood. One
reason for this is the lack of an appropriate animal model.
NMHC-IIA knockout mice die at an early embryonic stage
(E6.5–E7.5),18 whereas heterozygous mice are viable and
healthy.19 The knockout embryos fail to organize normal
germ layers, and therefore tissue-derived knockout cells are
not available. Here, we use the zebrafish as a model to study
the role and function of NMHC-IIA in the glomerulus. The
zebrafish larvae develop a simplified kidney, the pronephros,
consisting of two nephrons with a single central glomer-
ulus.20–23 The architecture and the function of the
glomerulus of the zebrafish larvae are highly similar to the
mammalian glomerulus and are therefore an accessible
system to study the role of Myh9.24–27 Moreover, the zebrafish
is transparent and easy to manipulate. Proteins can be
knocked down by microinjection of morpholinos into the
fertilized eggs. Furthermore, injection of fluorescent dextran
allows to study the filtration process directly in living larvae.
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In this paper, we reveal the essential role of NMHC-IIA in
the formation of the glomerular tuft and of the filtration
barrier in the pronephros of zebrafish larvae. Moreover,
by measurement of the blood clearance of microinjected
fluorescent dextran with different molecular sizes in living
larvae, we could determine the influence of NMHC-IIA on
the filtration process in vivo.
RESULTS
Zebrafish NMHC-IIA (zNMHC-IIA) is expressed in podocytes
and endothelial cells
For characterization of the cellular localization of zNMHC-IIA
in the glomerulus, we stained cryosections of zebrafish larvae
(3 d.p.f.) with an antibody against zNMHC-IIA. We found that
zNMHC-IIA was expressed in podocytes (Figure 1a and d). For
better identification of podocytes, we used a transgenic zebrafish
line with a podocyte-specific enhanced green fluorescent protein
(eGFP) expression, which is under the control of the wt1b
promoter (wt1b:eGFP; Figure 1b).28 Furthermore, zNMHC-IIA
was also found in mesangial cells and endothelial cells by
immunoelectron microscopy (Figure 1e and f).
Knockdown of zNMHC-IIA causes edema
We identified the zebrafish Myh9 ortholog by searching the
zebrafish genome (Ensemble zebrafish genome assembly).
The zebrafish Myh9 gene coding for the 1754 amino-acid
zNMHC-IIA protein is located on chromosome 6 on posi-
tion 8,452,022. Homologs exist in mice and humans, with
alignment scores of 82.6% and 83.3%, respectively.
To study the effects of selective zNMHC-IIA knock-
down, we used a morpholino antisense oligonucleotide
(zMyh9-MO) targeting the 50-untranslated region of the
zMyh9 mRNA (transcript ID: ENSDART00000011353;
protein ID: ENSDARP00000021727) including the start
codon, preventing zMyh9 mRNA translation. To test the
efficiency of the knockdown, a western blot using an anti-
body against zNMHC-IIA was performed, showing a reduced
signal in zMyh9-MO morphants as compared with larvae
spawned from eggs injected with a control morpholino
(ctrl-MO), respectively (Supplementary Figure S1 online).
Injection of zMyh9-MO (1 mmol/l) into fertilized eggs at the
two-cell stage resulted in pronounced pericardial and yolk sac
edema (41.3±4.4% at 4 d.p.f., n¼ 4074 larvae in 27 indepen-
dent experiments; Figure 2c–e). Furthermore, we observed
heart-folding defects often associated with a 40% slower
heart rate as compared with the controls (data not shown). A
few larvae showed a slight dorsal bending and shortening of
the body axis after 3 d.p.f. The knockdown of zNMHC-IIA
did not lead to a significant increase in mortality of larvae
at 5 d.p.f. (29.4±3.6%) as compared with ctrl-MO larvae
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Figure 1 | Localization of zebrafish NMHC-IIA (zNMHC-IIA) in the pronephros of zebrafish larvae. Cryosections (20 mm) of zebrafish
larvae (3 d.p.f.) injected with control morpholinos were immunostained with an antibody against zNMHC-IIA (red in a). Podocytes are
strongly stained in the cell body and processes identified by the podocyte-specific expression of eGFP (green in b). To identify all nuclei, the
sections were stained with DAPI (blue in c and d). The arrow (Po) in d (overlay of a–c) shows the cell body of a podocyte. The arrowhead
marks podocyte processes. Immunogold staining of zebrafish larvae (e–f) showed a staining for NMHC-IIA in podocytes (green circles), in
mesangial cells (blue circles), and in endothelial cells (red circles). DAPI, 4’,6-diamidino-2-phenylindole; EC, endothelial cell; eGFP, enhanced
green fluorescent protein; FP, podocyte foot processes; M, mesangial cell, NC, notochord; NMHC, non-muscle myosin heavy chain;
Po, podocyte.
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(20.3±2.4%). To verify the specificity of the zNMHC-IIA
knockdown, we repeated the experiments with a different
morpholino oligonucleotide (zMyh9-MO-b), directed against a
nonoverlapping region upstream of the target used previously.
The resulting phenotype was indistinguishable from that of
the first experiments (not shown). Edema developed in
55.8±4.1% of the zMyh9-MO-b-injected larvae (n¼ 646
larvae in eight individual experiments), as compared with
8.0±3.6% in ctrl-MO-injected larvae. The phenotype simila-
rity caused by the two morpholino oligonucleotides strongly
suggests specific knockdown of the intended target.
The presence of a pericardial edema after micro-
injection of the zMyh9-MO was taken as an indication for
abnormalities in glomerular filtration.20–22 We have used the
degree of severity to distinguish between a mild and a strong
phenotype, as detailed in Figure 2. Both types of zMyh9-MO
led to the development of mild and strong phenotypes
at a ratio of about 2:1.
Inhibition of zNM-II by blebbistatin causes defects similar
to zNMHC-IIA knockdown
Blebbistatin inhibits NM-II function, making it a useful
control of zNMHC-IIA knockdown experiments. Zebrafish
larvae treated with 200 mmol/l blebbistatin at 2 d.p.f. for
24 h (n¼ 127 larvae in three independent experiments)
developed noticeable pericardial edema at 4 d.p.f. (97.3±
4.6%, compared with 1.7±2.9% of untreated control
animals). Treatment at 3 d.p.f. led to the development of
large pericardial and yolk sac edema similar to those of the
strong phenotype after zNMHC-IIA knockdown, as defined
above. The structural defects in the zebrafish glomerulus
resulting from blebbistatin treatment were also very similar
to those caused by zNMHC-IIA knockdown. Specifically,
GBM thickening, GBM bulges with enfolded foot processes, a
loss of endothelial fenestration, and foot process-like
protrusions into Bowman’s space were observed (Supple-
mentary Figure S2 online).
Injection of zMyH9-MO leads to a malformation of the
glomerular capillary tuft
In order to study the role of zNMHC-IIA in zebrafish
glomeruli, we performed confocal z-scans on 60 mm cryosec-
tions (Figure 3) and light microscopy on 800 nm semithin
sections (Figure 4) of zNMHC-IIA knockdown larvae at
5 d.p.f. Glomeruli of larvae with mild phenotypes were
reduced in size, which often coincided with a dilated
Bowman’s space. Three-dimensional image reconstructions
from confocal image stacks (Supplementary Video S1 online)
also showed a marked deviation from the typical globular
shape of control glomeruli (Supplementary Video S2 online).
Glomerular capillaries of these larvae appeared to be delayed
in development. Only a few capillaries were formed showing
a dilated or not fully developed shape (Figures 3d–f and 4c).
Individuals with a pronounced phenotype mostly failed
to develop glomerular capillaries at all. In addition, adjacent
blood vessels such as the dorsal aorta and the cardinal
vein were highly dilated (Figure 4d). However, other capil-
laries outside the glomerulus were not affected (Supple-
mentary Figure S3 and Supplementary Video S3 online) and
were indistinguishable from the control (Supplementary
Video S4 online), suggesting that the malformation is specific
for the glomeruli.
Although the total number of podocytes appeared reduced
in comparison with the control, the formation of foot
processes was unchanged. Interestingly, some podocytes
covered with their foot processes the adjacent dilated aorta
(Figure 4d). In addition to this observation, we found that
the number of mesangial cells (arrowheads in Figure 3b) was
significantly reduced in zMyh9 knockdown larvae depending
on the degree of severity of the phenotype.
zNMHC-IIA is essential for the proper ultrastructure of
endothelial cells, GBM, and podocytes
To study ultrastructural effects due to knockdown of zMyh9,
electron microscopy of ultrathin sections of larvae was
performed at 4 and 5 d.p.f. In agreement with the observation
by light microscopy, mesangial cells were rare or absent in
zMyh9 knockdown larvae. A slight thickening of the GBM
(asterisk in Figure 5b and c) and a significant reduction of
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Figure 2 |Phenotypic analysis of zebrafish NMHC-IIA
(zNMHC-IIA) knockdown by morpholino injection.
Non-injected zebrafish larvae (a) at 4 d.p.f. were compared with
larvae spawned from eggs injected with ctrl-MO (b) and
zMyh9-MO (c, d), respectively. zNMHC-IIA knockdown effects
comprised dorsal bending, body axis shortening, the formation of
pericardial edema (arrows in c, d), and yolk sac edema (arrowhead
in d) of variable size. A mild phenotype is shown in c, a strong
phenotype in d. The statistical analysis of 27 individual
experiments (with 4074 larvae) shows that edema formation is
strongly associated with zNMHC-IIA knockdown (e) at 5 d.p.f.
ctrl-MO, control morpholino; NMHC, non-muscle myosin heavy
chain.
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endothelial fenestrations were evident in all zMyh9-MO-
treated larvae studied with electron microscopy (n¼ 6).
Larvae microinjected with the ctrl-MO developed normal
fenestrations (Figure 5a).
No striking effects on podocyte morphology were evident
in zMyh9 knockdown larvae. The vascular surface was
completely covered by normally developed, interdigitating
foot processes with slit diaphragms in between. However,
the GBM appeared nonuniformly thickened, displaying
locally isolated, highly disordered bulges (Figure 5e). We
also repeatedly observed a splitting of the lamina densa of
the GBM. Naked patches of GBM, as would be the result of
podocyte loss, could not be found in any case. In larvae with
a pronounced phenotype, the interdigitating foot processes
were locally disordered and irregular. Interestingly, many
podocytes displayed a ‘microvillous transformation’, with
interdigitating processes protruding into Bowman’s space
(Figure 5f). Between these protrusions, diaphragm-like
structures were observed.
zNMHC-IIA knockdown larvae exhibit decreased glomerular
filtration and an intact barrier function
To assess the effects of zNMHC-IIA knockdown on the
integrity of the filtration barrier, we studied the filtration
process in living zebrafish larvae by microinjection of 10 and
500 kDa fluorescence-labeled dextran. 4 d.p.f. zMyh9-MO
microinjected wt1b:eGFP larvae with a mild phenotype and
ctrl-MO-treated larvae were injected with a mixture of
500 kDa dextran tagged with FITC and 10 kDa dextran
conjugated to the Alexa 647 dye (Invitrogen, San Diego, CA)
into the caudal vein (Figure 6a and b). For these experiments,
only individuals with a heart rate close to that of untreated
larvae were used. Live imaging of the pronephric proximal
tubules showed an accumulation of 10 kDa dextran in the
epithelium of zMyh9-MO, as well as ctrl-MO-injected larvae
30 min after injection (Figure 6b). However, the 24 h vascular
clearance of 10 kDa dextran in zMyh9-MO-treated larvae
showed a significant 3.4-fold reduction as compared with
ctrl-MO-injected larvae (Figure 6c). In contrast, neither
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Figure 3 |Consecutive optical sections of glomeruli. Consecutive optical sections of ctrl-MO (a–c) and zMyh9-MO glomeruli (d–f). The
images of each section are spaced 2.5 mm apart. Knockdown glomeruli display a deformed morphology with a failure in capillary loop
formation (arrows in e) and missing mesangial cells (arrowheads in b). Bar¼ 10mm. Arrows, capillary lumen; arrowheads, mesangial cells;
blue, 4’,6-diamidino-2-phenylindole staining of cell nuclei; Bs, Bowman’s space; ctrl-MO, control morpholino; green, podocyte-specific
enhanced green fluorescent protein expression; red, F-actin.
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Figure 4 | Semithin sections of 5 d.p.f. larvae. The untreated
control larvae (a) and the control morphants (b) appear
indistinguishable. In a mild phenotype (c), zebrafish NMHC-IIA
(zNMHC-IIA) knockdown larvae show a malformed glomerular tuft
with a significant reduced number of capillary loops as compared
with the control (arrowheads in a and c). In pronounced
phenotypes (d), glomerular capillaries cannot be identified. The
asterisk shows a highly distended aorta covered by podocytes
instead of the glomerular capillaries. Bs, Bowman’s space; NC,
notochord; NMHC, non-muscle myosin heavy chain; Po, podocyte;
Tu, pronephric tubule.
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controls nor morphants displayed 500 kDa uptake within
proximal tubular cells at any time indicated. In addition, the
24 h vascular clearance of 500 kDa dextran did not differ
between controls and morphants (Figure 6c).
zNMHC-IIA knockdown does not compromise zebrafish
platelet function
As platelets are severely affected in Myh9-related diseases, we
assessed the role of zNMHC-IIA regarding platelet morphol-
ogy and function. Platelets from ctrl-MO- and zMyh9-MO-
treated larvae were stained by injection of a mixture of
DiO and 40,6-diamidino-2-phenylindole into the dorsal vein
of 3 d.p.f. larvae. At 10–20 min after injection, we studied
platelet recruitment and thrombus formation by in vivo laser
scanning microscopy in response to tail wounding. In three
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Figure 5 |Glomerular ultrastructure of 5 d.p.f. ctrl-MO (a) and
zMyh9-MO larvae (b–f). Larvae spawned from eggs injected with
the ctrl-MO (a) possess normally developed capillaries with a
fenestrated endothelium, covered by well-organized podocyte
foot processes (inset in a). zMyh9-MO larvae with a mild
phenotype (b) are characterized by glomerular basement
membrane (GBM) thickenings (asterisk) and reduced
fenestrations, but normal podocyte foot processes (inset in b).
In addition, zMyh9-MO with a pronounced phenotype (c–f) exhibit
focal GBM bulges (asterisk in c) with enfolded foot processes
(inset in c), often surrounded by a lamina densa (arrowheads in e).
Foot process-like protrusions extend into Bowman’s space and
form small interdigitating contacts connected by slit membrane-
like structures (arrows in f). Images e and f are magnifications of d.
Ad, aorta dorsalis; Bs, Bowman’s space; CL, capillary lumen;
ctrl-MO, control morpholino; GBM, glomerular basement
membrane; Po, podocyte.
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Figure 6 | Effects of zebrafish NMHC-IIA (zNMHC-IIA)
knockdown on the integrity of the filtration barrier.
zNMHC-IIA knockdown larvae (3 d.p.f.) were injected with a 1:1
mixture of 10 kDa dextran and 500 kDa dextran tagged with Alexa
Fluor 647 and FITC, respectively. Dextran (10 kDa) has been
distributed in the extracellular space 30min after intravascular
injection (a). Dextran (10 kDa, red) easily passes the filtration
barrier in untreated larvae and accumulates in the apical
compartment of pronephric tubular cells (b) expressing eGFP
(green). From confocal image stacks of a section of the dorsal
aorta and the cardinal vein (box in a), the relative changes of the
mean fluorescence intensities within the vasculature were
calculated for both colors (c). The intensity curve of 500 kDa
dextran in morphants and controls is almost identical. The
decrease of 500 kDa dextran over time is mostly due to slow
leakage into surrounding tissue and FITC bleaching. FITC
fluorescence intensity within the tubule remained zero at all
times. However, clearance of 10 kDa dextran after 24 h is reduced
about threefold in morphants as compared with the controls. Ctrl,
control; Dex, dextran; eGFP, enhanced green fluorescent protein;
FITC, fluorescein isothiocyanate; MO, morpholino; NMHC,
non-muscle myosin heavy chain.
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independent series of experiments (each with n¼ 4 larvae),
we could not detect any significant differences between
platelets of ctrl-MO- and zMyh9-MO-treated larvae. This is
consistent with the mild phenotype in humans with MYH9
disorder.
DISCUSSION
It has become evident that mutations of the MYH9 gene are
responsible for the development of glomerulosclerosis11–14
and end-stage renal disease.15,16 Owing to the fact that Myh9
knockout mice are not viable and heterozygous mice show no
phenotype,18,19 we studied the role of zMyh9 in zebrafish
larvae via knockdown by morpholino microinjection. This
study shows for the first time that larvae with reduced
expression of zNMHC-IIA develop a severe glomerular
phenotype.
Studying the pronephros of zMyh9 knockdown larvae, we
observed a severe malformation of the glomerular capillary
tuft. Endothelial and mesangial cells were the predominantly
affected cell type of the glomerulus. Endothelial fenestrations
failed to develop completely in those zMyh9 knockdown
larvae that exhibited a pronounced phenotype, accompanied
by a severely reduced formation of capillary loops. Strilic
et al.29 have shown that the vascular lumen formation of the
aorta in mice is dependent on vascular endothelial growth
factor and NM-II. Moreover, it is reported that the
angiogenic function of endothelial cells is directly dependent
on NMHC-IIA.30,31 The in vitro experiments of Fischer
et al.32 have shown that NM-II mediates cortical tension
to guide endothelial cell branching and migration in three
dimension. The malformation of the endothelium and
capillaries after zMyh9 knockdown is specific for the
glomerulus in zebrafish. By studying the fli:eGFP zebrafish
larvae, expressing GFP in the endothelium, we were able to
demonstrate that other vessels of the zebrafish larvae are not
affected. It might be concluded that zMyh9 is essential for the
generation of the glomerular capillary tuft and its endothelial
fenestration only, or that maternally supplied zNMHC-IIA is
sufficient for vessel formation but not for the glomerular tuft.
In addition, we found a complete loss of mesangial cells in
those larvae that exhibited a pronounced phenotype,
resulting in highly dilated glomerular capillaries. It is not
clear whether this is a direct effect of zNMHC-IIA knock-
down in mesangial cells, affecting their ability to migrate and
initiate capillary looping, or whether this is an indirect effect
of a missing signal from endothelial cells to recruit mesangial
cells, e.g., via platelet-derived growth factor-B.33 In fact, little
is known about the influence and function of NM-II in
mesangial cells. However, recently published papers describe
the role of NM-II in front–back and apical–basal polarity, as
well as in cell migration in different cell types.4,6 In addition
to the induction of contractility and stabilization of actin
filaments by NM-II, it could be demonstrated by Wilson
et al.34 that NM-II is important for actin network dis-
assembly, one requirement for organized migration of cells.
Therefore, the loss of zNMHC-IIA function may directly
influence the migration of mesangial cells, which is necessary
for proper glomerular tuft formation.
Another possibility might be that podocytes are involved
in the malformation of the glomerulus. It is well known that
podocytes have a profound influence on both mesangial and
endothelial cells. Podocytes regulate the migration and
differentiation of endothelial cells via secretion of vascular
endothelial growth factor-A. Overexpression of vascular
endothelial growth factor-A in cultured adrenal endothelial
cells35 and in glomerular endothelial cells36 induces fenestra-
tion in vitro. Moreover, the selective deletion of vascular
endothelial growth factor-A in podocytes in mice results in
marked defects on endothelial cell in growth, proliferation,
and differentiation.37 These mice are further unable to
develop fenestrations of the endothelium.
By studying the ultrastructure of zMyh9 knockdown
podocytes, we detected a pronounced disturbance of the
highly ordered foot processes. Moreover, major processes
showed microvillus-like protrusions into Bowman’s space.
This might also be an indication of a disturbance of podo-
cyte polarity. However, we observed neither foot process
effacement nor loss of slit diaphragms. This seems to be in
contrast to the observation that some patients with mutation
in the MYH9 gene develop glomerulosclerosis during
their life.11–14,16 However, it is important to point out that
glomerulosclerosis develops late in adulthood in these
patients. Furthermore, even within the same family, individ-
uals with the MYH9 mutation have different risks for
developing renal failure. This strongly indicates that the
MYH9 mutation may not be the only determinant for the
development of a renal phenotype.38
In addition to the changes in podocyte morphology,
we observed a focal disturbance of the GBM in zMyh9
knockdown zebrafish larvae. Some areas of the GBM were
thicker than in control larvae with foot processes enfolded
in the thickened GBM. Thickening of the GBM is typical
for diabetic nephropathy39–41 and was found in MYH9-
associated diseases, such as the Fechtner and Epstein
syndromes.16,42,43 Moreover, focal thickening of the GBM,
together with loss of slit diaphragms, was reported in
knockout mice of DDR1, which is a receptor for collagen
IV, and which is involved in matrix remodeling.44 Interest-
ingly, Huang et al.45 showed that DDR1 is a binding partner
of NMHC-IIA regulating cell spreading and motility. In this
context, it is of great interest that Meyer zum Gottesberge
et al.46 found that DDR1 knockout mice also suffer from
inner ear defects and hearing loss similar to patients with
several MYH9-associated diseases. Further studies are neces-
sary to determine whether there is an interaction between
DDR1 and zNMHC-IIA in the pronephric glomerular
development in zebrafish.
In the present study, we further analyzed the consequences
of glomerular malformation regarding the filtration process
in vivo. Advancing the method originally described,20,21 we
were able to study glomerular filtration and barrier func-
tion in living zebrafish larvae using fluorescence microscopy.
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We found that macromolecules do not cross the glomerular
filtration barrier of zMyh9 knockdown larvae, as it would be
expected given the overall normally developed foot processes
and slit diaphragms. However, the glomerular filtration rate
appears to be significantly diminished, which might be the
result of an endothelium without fenestration and a reduced
glomerular capillary surface area.
As a control for specific functional alteration of the
podocytes and for the potential generalizability of our results
to the human system, we also assessed platelet function in
zNMHC-IIA knockdown larvae. Similar to the phenotype
observed in humans affected by heterozygous MYH9
mutations, we did not observe a major platelet defect in a
laser injury model, which, however, is somewhat in contrast
to the prolonged bleeding time in mice with megakaryocyte-
specific MYH9/ knockout.47
In summary, our study demonstrates that zMyh9 has an
essential role in the development of the pronephric glomer-
ulus in zebrafish. Knockdown of zMyh9 mainly affects
glomerular endothelial and mesangial cells compromising
the formation of the glomerular capillary tuft.
MATERIALS AND METHODS
Zebrafish stocks
Zebrafish were reared and maintained as previously described.48 The
wt1a:eGFP strain expresses eGFP under the wt1a promoter in
podocytes and parietal epithelial cells. The wt1b:eGFP strain exhibits
additional eGFP expression in pronephric tubular cells. Fli:eGFP
(kindly provided by M Brandt, Dresden, Germany) zebrafish express
eGFP in endothelial cells. All zebrafish were grown and mated at
28.5 1C. Embryos were kept and handled in E3 solution.
Morpholino oligo-mediated knockdown
Morpholino oligonucleotides were designed by Gene Tools, LCC
(Philomath, OR) to target the 50-untranslated region of the zMyh9
mRNA (zMyh9-MO), including the start codon. The following
sequence was used: 50-GAACTTCTCTGCGTCTGACATTTTG-30. As
a verifying control, an additional morpholino oligonucleotide
(zMyh9-MO-b) was designed, targeting a nonoverlapping, upstream
part of the 50-untranslated region. The following sequence was
used: 50-TCCCGGAGCCGTTCGTCGAGAACTT-30. For control
larvae, eggs were injected with the standard ctrl-MO (Gene Tools,
LCC) with the sequence 50-CCTCTTACCTCAGTTACAATTTATA-30.
Morpholinos were diluted to a concentration of 1 mmol/l. A volume
of B3 nl/zebrafish embryo was injected into the yolk at the 2–4 cell
stage. A microinjector (transjector 5246, Eppendorf AG, Hamburg,
Germany) was used for morpholino injection. After injection,
the embryos were maintained in embryo medium.
Western blot
Zebrafish eggs were injected with zMyh9-MO and ctrl-MO, respectively,
as described above. For each preparation, the lysate of 10 larvae at
3 d.p.f. (days post fertilization) was subjected to protein isolation and
gel electrophoresis as it was described by Westerfield.48 After blotting, an
antibody was used to detect zNMHC-IIA (Covance, Emeryville, CA).
NM-II inhibition with blebbistatin
Zebrafish larvae were treated with 200mmol/l blebbistatin (Sigma-
Aldrich, Mu¨nchen, Germany) for 24 h at 2 or 3 d.p.f. They were
subsequently returned to E3 medium for another 24 h and analyzed
for edema formation or fixed and sectioned as described below.
Dextran microinjection and time-lapse microscopy
Larvae were anaesthetized with 0.1–0.5% tricaine (Sigma-Aldrich)
in E3 solution. For the filtration analysis, larvae at 3 d.p.f. were
injected with a 1:1 mixture of 25 mg/ml Alexa Fluor 647-conjugated
10 kDa dextran and 10 mg/ml FITC-conjugated 500 kDa dextran
(Invitrogen) into the caudal vein using Femtotips micropipets
(Eppendorf AG). The larvae were transferred to E3 medium for
recovery, anesthetized again 30 min after injection, and positioned
on their sides in a glass-bottom Petri dish. Confocal three-
dimensional image stacks of a section of the dorsal aorta and the
cardinal vein caudal of the swim bladder were recorded with a step
size of 630 nm at 30 min, 90 min, 240 min, and 24 h after dextran
injection. The larvae were transferred to E3 medium between
recordings. A dedicated Matlab analysis routine (Mathworks, Natick,
MA) was used for semiautomated image segmentation and analysis.
The mean FITC and Alexa Fluor 647 fluorescence intensities within
the vascular lumen at each time interval were measured for 12
zNMHC-IIA morphant larvae and 20 control larvae.
Immunohistochemistry
For fluorescent microscopy of zebrafish cryosections, larvae
at 5 d.p.f. were fixed in 2% paraformaldehyde in phosphate-buffered
saline (PBS) at 4 1C overnight, then washed in 1 PBS, and
incubated in 30% sucrose in 1 PBS at 4 1C overnight. Larvae were
then embedded in Tissue-tek (Sakura, Staufen, Germany) and snap
frozen in liquid nitrogen. Cryostat sections (60mm) were perme-
abilized with 0.3% Triton X-100 (Merck, Darmstadt, Germany) for
2 min and stained with phalloidin 1:100 and 1 mg/100 ml Hoechst
33342 (Sigma-Aldrich) for 30 min. For zNMHC-IIA staining,
antibodies were purchased from Covance and used at 3 mg/ml for
1 h on ice. After washing three times with 1 PBS, Cy3-conjugated
anti-rabbit secondary antibodies (Jackson ImmunoResearch Lab-
oratories, Suffolk, GB) were applied at 5 mg/ml for 1 h on ice. The
samples were washed and mounted in Mowiol for microscopy
(Carl Roth, Karlsruhe, Germany).
Imaging
Edema formation was controlled by use of a Stemi SV11 stereo-
microscope (Carl Zeiss Microimaging, Jena, Germany). GraphPad
Prism version 5.0 (GraphPad Software, San Diego, CA) was used for
the statistical analysis of edema formation and larvae mortality.
Images of semithin sections were recorded with a Zeiss Axioplan
microscope (Carl Zeiss Microimaging), using a  40 air objective
( 40/0.75 Plan Neofluar). For images of whole zebrafish larvae,
a  2.5 air objective ( 2.5/0.075 Plan Neofluar) was used.
Confocal microscopy was performed with a Leica TCS SP5
microscope (Leica Microsystems, Wetzlar, Germany). For cryo-
sections, a  40 oil-immersion objective (HCX PL APO  40/1.25)
was used. Image stacks of live zebrafish larvae were recorded with
a  20 water immersion objective (HCX PL APO  20 /0.7).
Three-dimensional image reconstructions were created with the
Volocity software (Improvision, Coventry, UK).
Transmission electron microscopy and semithin sections
Larvae at 3–5 d.p.f. were fixed with 1.5% glutaraldehyde and 0.5%
paraformaldehyde in 0.1 mol/l Na2HPO4 containing 0.12 mmol/l
CaCl2 plus 3% sucrose at 4 1C overnight. Fixed larvae were washed
in 1 PBS, postfixed in 1% osmium tetroxide for 2 h, and
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dehydrated through a graded acetone series. Embedding was
performed with araldite (Fluka Chemie AG, Buchs, Switzerland).
Sections were cut on an Ultracut UCT ultramicrotom (Leica GmbH,
Heidelberg, Germany). Semithin sections (800 nm) were collected
on glass slides and stained with a 1:1 mixture of 1% azure II and 1%
methylene blue according to Richardson et al.49
Ultrathin sections (70 nm) were placed on copper grids and were
contrasted with 5% uranyl acetate for 5 min. After incubation with
lead citrate according to Sato50 for 3 min, the grids were examined
with a JEOL JEM 1011 electron microscope (JEOL, Tokyo, Japan).
For immunoelectron microscopy, fixed larvae were embedded in
LR White (Plano, Wetzlar, Germany). Ultrathin sections were incu-
bated with the antibody against zNMHC-IIA (1:10) overnight. After
the washing procedure, the ultrathin sections were incubated with
a secondary antibody conjugated with 10 nm colloidal gold for 1 h.
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SUPPLEMENTARY MATERIAL
Figure S1. Western blot of zMyh9-MO morphants.
Figure S2. Edema formation and ultrastructural glomerular defects
after blebbistatin treatment.
Figure S3. Maximum projections of confocal image stacks of blood
vessels in the trunk of 4 d.p.f. zebrafish (lateral view).
Video S1. Three-dimensional reconstruction of a confocal image
stack of a cryosectioned zMyh9-MO larva (5 d.p.f., 14 mm).
Video S2. Three-dimensional reconstruction of a confocal image
stack of a cryosectioned ctrl-MO larva (5 d.p.f., 26mm).
Video S3. Confocal z-scan of the trunk (lateral view) of a zMyh9-MO
larva (4 d.p.f.) expressing eGFP in endothelial cells.
Video S4. Confocal z-scan of the trunk (lateral view) of a ctrl-MO larva
(4 d.p.f.) expressing eGFP in endothelial cells.
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